Profil
Mr. Stuart Knight is a Chief Information Officer & Senior Vice President at Theravance Biopharma, Inc. Mr. Knight was previously employed as a Head-Global Markets IT & Infrastructure by Galderma Pharma SA and a Vice President-Information Technology by Ipsen Biopharmaceuticals, Inc. He received his undergraduate degree from London South Bank University.
Postes actifs de Stuart Knight
| Sociétés | Poste | Début |
|---|---|---|
| THERAVANCE BIOPHARMA, INC. | Directeur Technique/Scientifique/R&D | 01/11/2014 |
Anciens postes connus de Stuart Knight
| Sociétés | Poste | Fin |
|---|---|---|
Galderma Pharma SA
Galderma Pharma SA Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company specializes in dermatological treatments and skin care products | Directeur Technique/Scientifique/R&D | 01/10/2014 |
Ipsen Biopharmaceuticals, Inc.
Ipsen Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company | Directeur Technique/Scientifique/R&D | 01/01/2013 |
Formation de Stuart Knight
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Galderma Pharma SA
Galderma Pharma SA Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company specializes in dermatological treatments and skin care products | Health Technology |
London South Bank University
London South Bank University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Theravance Biopharma, Inc.
Theravance Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of human therapeutics products for respiratory diseases | Health Technology |
Ipsen Biopharmaceuticals, Inc.
Ipsen Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company | Health Technology |
















